http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011036467-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7ea20fd6388063c7ec55fdc97efe9473 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-64 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 |
| filingDate | 2010-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eed7a3955817ae99fb604a5a158e4daf |
| publicationDate | 2011-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2011036467-A1 |
| titleOfInvention | Products useful in the treatment of haemophilia |
| abstract | Factor VIII bound to a lymphotoxin is useful in treating haemophilia A inhibitors. The lymphotoxin may be selected from corticosteroids, vincristine, rituxiMab, or any other agent which causes lymphocyte cell death. The lymphotoxin may be bound to Factor VIII directly, via a linker, via an antibody, or by other suitable methods. The invention allows targeted and safe treatment. Similarly, Factor IX bound to a lymphotoxin is useful in treating haemophilia B inhibitors. |
| priorityDate | 2009-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 29.